Search
Displaying results 1131 to 1140 of 1206.
Stronger together: EMBL and Helmholtz Health formalise their collaboration in research and development
Data science, microbiome research, environmental research, infection biology, and health and disease research with a special focus on cancer and antibiotics – these interdisciplinary topics are the focus of the memorandum of understanding (MoU) signed by EMBL and…
Want some more?
Your new paper is about the natural product darobactin. Where does this molecule come from and why is it so interesting for you? Darobactin is an antibiotic that was first described by Imai and colleagues in the journal Nature in 2019 and is naturally produced by the…
Helmholtz Data Science Career Day
At the Helmholtz Data Science Career Day on September 22, 2021, centers and partner institutions will now come together to present career opportunities from PhD to professorship in all research areas to international Data Science talents. The early afternoon conference…
Strengthening of Drug Bioinformatics at the Saarbrücken Site
With additional funding of €100,000, the Klaus Faber Foundation supports Kalinina's project "bioINFpro," which aims to expand drug research through AI-based methods and develop new antibiotics against antibiotic-resistant bacteria. In doing so, the foundation makes a…
Coming Soon
Four new junior research groups at the Helmholtz Centre for Infection Research
The ability to react to changes, to survive in existing habitats and to colonize new ones is a prerequisite for prevailing in the course of evolution. These principles of resilience and adaptability, especially in microorganisms, are at the heart of the HZI project…
Jump start for young female scientists
What sparked your interest in pharmaceutical research and how did you come to HIPS in particular? I find pharmaceutical research so exciting because it is so interdisciplinary and translational. When I decided to study pharmacy, I deliberately didn't want to focus on…
